The Cure Our Children Foundation New and Emerging Treatments for Ewing's Sarcoma Weblog (http://www.cureourchildren.org) :: Initial phase I study of XR5944, a novel DNA and RNA targeting agent, and Related American Society of Clinical Oncology Trial Abstracts

This Month

Month Archive

Year Archive

Previous:	Xenova Group PLC -- Tariquidar Phase I Paediatric Study Data Presented at ASCO
Next:	Pediatric, Adolescent and Young Adult Oncology Drugs in the Pipeline

Initial phase I study of XR5944, a novel DNA and RNA targeting agent, and Related American Society of Clinical Oncology Trial Abstracts

by Barry Sugarman on Sat 28 Aug 2004 03:38 AM EDT | Permanent Link

Posted to: